Kidney cancer: Characterizing late recurrence of renal cell carcinoma

FicarraV.; NovaraG.

首页> 外文期刊>Nature reviews. Urology >Kidney cancer: Characterizing late recurrence of renal cell carcinoma

【24h】

Kidney cancer: Characterizing late recurrence of renal cell carcinoma

机译：肾癌：表征肾细胞癌的晚期复发

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Very few studies have followed patients with renal cell carcinoma for long enough to characterize late relapses. Newly published research suggests that late-recurring tumours are more likely to be of low nuclear grade and show a better response to first-line targeted therapy than early relapsing cancers.

机译：很少有研究对肾细胞癌患者进行足够长的随访以表征晚期复发。最新发表的研究表明，与早期复发的癌症相比，晚期复发的肿瘤更有可能是低核级的，并且对一线靶向治疗的反应更好。

著录项

来源
《Nature reviews. Urology》 |2013年第12期|共3页
作者
FicarraV.; NovaraG.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词

相似文献

外文文献
中文文献
专利

1. Kidney cancer: Characterizing late recurrence of renal cell carcinoma [J] . FicarraV., NovaraG. Nature reviews. Urology . 2013,第12期

机译：肾癌：表征肾细胞癌的晚期复发
2. KIDNEY CANCER Recurrence in renal cell carcinoma: the work is not done [J] . Sun Maxine, Choueiri Toni K. Nature reviews. Urology . 2016,第5期

机译：肾癌肾细胞癌复发：工作尚未完成
3. Late recurrence of renal cell carcinoma: retrospective and collaborative study of the Japanese Society of Renal Cancer. [J] . Miyao N, Naito S, Ozono S, Urology . 2011,第2期

机译：肾细胞癌的晚期复发：日本肾脏癌学会的回顾性研究和合作研究。
4. When to Treat Metastatic Renal Cell Carcinoma Comorbidities, Systemic Therapy, and Active Surveillance in Metastatic Kidney Cancer [C] . Brian I. Rini Genitourinary Cancers Symposium . 2012

机译：何时治疗转移性肾细胞癌的组合，全身治疗，以及在转移性肾癌中的活跃监测
5. Characterizing the Mechanism of Tumor Suppression by PBRM1 in Clear Cell Renal Cell Carcinoma. [D] . Schoenfeld, David. 2016

机译：表征PBRM1在透明细胞肾细胞癌中抑制肿瘤的机制。
6. Repeat partial nephrectomy for recurrence of Von Hippel-Lindau-related renal cell carcinoma in an autotransplanted kidney [O] . D. Perri, G. Marchioro, G. Bondonno, 2021

机译：重复部分肾切除术治疗肾脏肝林道相关肾细胞癌中的复发
7. PCN72 HEALTH-RELATED QUALITY OF LIFE (HRQOL)AND KIDNEY CANCER-RELATED SYMPTOMS IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC)TREATED WITH SUNITINIB VERSUS INTERFERON (IFN)-ALFA IN A RANDOMISED, MULTINATIONAL PHASE III TRIAL: RESULTS FOR EUROPEAN AND US SUBSAMPLE ANALYSES [O] . Celia D, Li JZ, Bushmakin AG, 2007

机译：经随机，多次欧洲和第三阶段治疗的经舒尼替尼抗干扰素（IFN）-α治疗的转移性肾细胞癌（MRCC）患者的PCN72生命质量（HRQOL）和肾癌相关症状子样本分析

Kidney cancer: Characterizing late recurrence of renal cell carcinoma

摘要

著录项

相似文献

相关主题

期刊订阅